Vaxcyte (PCVX) Cash & Equivalents (2019 - 2026)
Vaxcyte (PCVX) reported Cash & Equivalents of $183.19 million for Q2 2026, down 40.3% from $306.74 million a year earlier and down 29.8% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Vaxcyte posted Cash & Equivalents of $173.96 million, down 55.2% from FY2024.
- Cash & Equivalents has declined for three consecutive years, with a five-year compound annual growth rate of -14.7% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $387.88 million in FY2024 (-2.4%), $397.45 million in FY2023 (-52.4%), $834.66 million in FY2022 and $68.99 million in FY2021 (-82.1%).
- Five-year quarterly Cash & Equivalents spans a low of $68.99 million in Q4 2021 and a high of $1.05 billion in Q3 2024.
- Year over year, Cash & Equivalents has now declined in each of the last seven quarters, with an average decline of 23.4% over the last eight quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q3 2022 (growth of 148.5%); the low point was Q4 2021 (a decline of 82.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $260.84 million (Q1 2026), $173.96 million (Q4 2025) and $281.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Vaxcyte | 8.24 Bn | 8.24 Bn | - | 183.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 183.19 Mn |
| Mar 31, 2026 | 260.84 Mn |
| Dec 31, 2025 | 173.96 Mn |
| Sep 30, 2025 | 281.08 Mn |
| Jun 30, 2025 | 306.74 Mn |
| Mar 31, 2025 | 346.85 Mn |
| Dec 31, 2024 | 387.88 Mn |
| Sep 30, 2024 | 1.05 Bn |
| Jun 30, 2024 | 518.67 Mn |
| Mar 31, 2024 | 611.51 Mn |
| Dec 31, 2023 | 397.45 Mn |
| Sep 30, 2023 | 545.13 Mn |
| Jun 30, 2023 | 531.03 Mn |
| Mar 31, 2023 | 380.45 Mn |
| Dec 31, 2022 | 834.66 Mn |
| Sep 30, 2022 | 278.40 Mn |
| Jun 30, 2022 | 238.17 Mn |
| Mar 31, 2022 | 201.74 Mn |
| Dec 31, 2021 | 68.99 Mn |
| Sep 30, 2021 | 112.04 Mn |
API Access
Vaxcyte Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();